RICHMOND, Va. and CARLSBAD, Calif., Jan. 7 /PRNewswire/ -- American International Biotechnology Services(TM) (AIBioTech(TM)), a division of Bostwick Laboratories(R), announced today that it has established a partnership with AutoGenomics wherein they will utilize the automated INFINITI(R) analyzer and multiple applications that they have validated.
"We are excited at this partnership and impressed with the test portfolio that is being offered by AIBioTech," said Fareed Kureshy, CEO of AutoGenomics. "The versatility of our BioFilmChip Microarray technology allows us to rapidly develop new applications to meet the needs of AIBioTech."
AIBioTech is one of the world's most comprehensive Contract Research Organizations. As an expert core laboratory, AIBioTech provides consultation on experimental design and offers services under GLP and non-GLP compliance. These services are offered individually or can be integrated to support product development from discovery-to-market with full Regulatory Support under FDA GLP Guidelines 21 CFR 58. http://www.aibiotech.com
CONTACT: Brent Sower, Executive Vice President of Marketing,
+1-804-967-9225, BSower@bostwicklaboratories.com; or Ramanath Vairavan, Sr.
Vice President Sales & Marketing, +1-760-804-7378, ext. 305,
Web site: http://www.autogenomics.com/